New Directions in Enantioselective C-H Functionalization
Project Number5R01GM099142-12
Former Number5R01GM099142-08
Contact PI/Project LeaderDAVIES, HUW M
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
Project Summary
The development of new synthetic methods has the potential to transform how pharmaceutical
drugs are made and even what types of compounds will be designed as potential targets. The
synthetic accessibility is a crucial component in the design of drugs and entirely new synthetic
strategies open up new vistas of potential targets for consideration. A transformation that has
generated considerable recent interest is C-H functionalization, because it represents a different
logic for how to join molecules together. One of the major challenges is to control the site
selectivity in substrates containing multiple C-H bonds. A promising approach has been the
rhodium-catalyzed reactions of donor/acceptor carbenes, which by using the right catalyst, will
allow selective reactions to occur at either primary, secondary of tertiary C-H bonds. A major,
limitation associated with this approach, however, is the narrow range of donor/acceptor carbenes
that are currently used, primarily limited to carbenes derived from vinyl- aryl- and
heteroaryldiazoacetates.
This proposal focuses on the development of new types of donor/acceptor carbenes, which will
greatly enhance the synthetic versatility of this promising methodology to access new chemical
space. This will be achieved by expanding the range of functionality that can be associated with
the donor/acceptor carbene chemistry, designing a new class of high symmetry bowl-shaped
chiral catalysts, and illustrating new strategic opportunities for catalyst-controlled C-H
functionalization applied to pharmaceutically relevant targets.
Public Health Relevance Statement
Project Narrative
The development of new synthetic methods has the potential to transform how
pharmaceutical drugs are made and even what types of compounds will be designed as potential
targets. The synthetic accessibility is a crucial component in the design of drugs and entirely
new synthetic strategies open up new vistas of potential targets for consideration. This proposal
is directed towards the development of catalyst-controlled methods for the selective
functionalization of C-H bonds and the illustration of how this chemistry can be applied to the
synthesis of pharmaceutically relevant targets.
No Sub Projects information available for 5R01GM099142-12
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM099142-12
Patents
No Patents information available for 5R01GM099142-12
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM099142-12
Clinical Studies
No Clinical Studies information available for 5R01GM099142-12
News and More
Related News Releases
No news release information available for 5R01GM099142-12
History
No Historical information available for 5R01GM099142-12
Similar Projects
No Similar Projects information available for 5R01GM099142-12